Effects of Small Doses of Bromazepam on Pupillary Function and on Flicker Perception in Normal Subjects

SummaryAs with other drugs it is necessary to look for changes induced by anxiolytics on vital signs, laboratory parameters and adverse events. In return, in a more specific way for anxiolytics, we will look at side effects at the central nervous system level with psychological and physiological battery tests. We will also assess the safety of use of anxiolytics in certain specific conditions, such as overdose or withdrawal and in certain populations such as the elderly, neonates and children. The assessment of safety and side effects, whatever the drug type studied, must come early in the developing process of a drug (phases I, II and III).

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Effects of Small Doses of Bromazepam on Pupillary Function and on Flicker Perception in Normal Subjects

Cited by 6 publications

References 0 publications

Arousal and the pupil: why diazepam-induced sedation is not accompanied by miosis

Arousal and the pupil: why diazepam-induced sedation is not accompanied by miosis

Benzodiazepine effects on flicker sensitivity: Role of stimulus frequency and size

Evaluation of safety and side effects in the process of anti-anxiety drug development *

Contact Info

Product

Resources

About